
ArchiMed-backed Bomi bolts on Deco Pharma
Italian logistics specialist Bomi, a portfolio company of healthcare-focused GP ArchiMed, has acquired Deco Pharma Servicios Logisticos.
With this acquisition, Bomi plans to build a large customer base in Spain and Portugal, and further strengthen its presence across southern Europe.
This add-on follows Bomi's acquisition of Logifarma, an Italian logistics business for the pharmaceutical industry; the bolt-on of Ecuador-based Integrated Logistics Services (ILS); and its recent purchase of Italian healthcare logistics specialist Florence Shipping.
Established in 1985 and based in Vaprio d'Adda, near Milan, Bomi specialises in transport, warehousing and supply-chain management for healthcare companies ranging from pharmaceutical and medical equipment manufacturers to hospitals, testing laboratories and outpatient services. The business operates in 20 countries across Europe, the Americas and Asia, and generates EBITDA of around €12m from revenues of €125m.
ArchiMed acquired Bomi in a €70m take-private in May 2019, de-listing the company from the Milan stock exchange. The GP invested in the business via its mid-market fund, Med Platform I, which was launched in 2018 with a target of €800m and held a final close on €1bn in August 2020.
Company
Headquartered in San Agustín de Guadalix, near Madrid, Deco Pharma specialises in logistics for the healthcare and pharmaceutical industries.
People
Bomi – Oscar Pérez (head of Iberia).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater